Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients

There are about 400 million chronic hepatitis B virus (HBV) infection patients worldwide, posing a serious threat to global public health security. In China, HBV infection occured mainly in the perinatal period or infants, and about 10% of patients in the immune tolerance stage spontaneously transit to the immune clearance …

  • 0 views
  • 21 Apr, 2022
  • 1 location
Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV (LIMT-2)

The Phase 3 LIMT-2 study will evaluate the safety and efficacy of Peginterferon Lambda treatment for 48 weeks with 24 weeks follow-up compared to no treatment for 12 weeks in patients

  • 1 views
  • 28 Jul, 2022
  • 15 locations
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple sclerosis (RRMS) and to assess the pharmacokinetics (PK) of BIIB017 in pediatric participants with RRMS in Part 1. In Part 2, the study will evaluate the long-term safety of BIIB017 and further …

magnetic resonance imaging brain
relapsing multiple sclerosis
interferon
  • 144 views
  • 25 Jul, 2022
  • 58 locations
Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia

suggests that these group are at risk of gradual disease progression and development of hepatocellular carcinoma. Peginterferon eliminates the hepatitis B virus through immune regulation and induction of

  • 0 views
  • 23 Mar, 2022
  • 1 location
Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis

Compared to TDF, peginterferon alfa 2a may has more therapeutic efficacy in hepatitis B surface antigen or e antigen seroconversion and anti-tumor occurrence in chronic hepatitis b patients. We

liver disease
hepatitis b surface antigen
interferon
fumarate
hepatitis
  • 3 views
  • 24 Feb, 2022
  • 1 location
Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 (ILIAD)

profile than other interferons because of the limited tissue distribution of its receptor. Peginterferon lambda is a long-acting form that has been studied extensively in human trials in viral hepatitis

antiviral drugs
interferon
fever
pharyngitis
sore throat
  • 176 views
  • 22 Mar, 2022
  • 5 locations
Pegintron to Treat Plexiform Neurofibromas in Children and Young Adults

pegylated preparation, peginterferon alfa-2beta (Pegintron) lengthens the plasma half-life and allows for administration once a week. A phase I trial of Pegintron for children and young adults

  • 55 views
  • 07 Nov, 2020
  • 1 location
A Prospective Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study)

after finished following clinical trail about A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B(OSST

interferon
combination therapy
chronic hepatitis
hepatitis b antigen
peginterferon
  • 16 views
  • 22 Jan, 2021
  • 10 locations
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B

This is a multicenter, prospective, real-world study, recruiting patients with chronic hepatitis B under anti-viral treatment. The recruited participants will receive peginterferon alpha based

entecavir
cirrhosis
tenofovir
hepatocellular carcinoma
hepatitis
  • 0 views
  • 30 May, 2021
  • 1 location
Antiviral Therapy for Patients With Liver Cancer After Surgery

This is a single-center, prospective, observational, real world study designed to evaluate the effects of peginterferon α-2b(pegabin) combined with nucleoside (acid) analogs (entecavir,ETV

cancer
  • 0 views
  • 24 Jul, 2022
  • 1 location